Thrombosis and Haemostasis · 2018 · 24 citations · 31 references
MedicineCardiologyClinical CardiologyInflammationInterventional CardiologyAcute Coronary Syndrome InterventionAcute Coronary SyndromesCardiac BiomarkersCardiovascular DiseaseCoronary Artery DiseaseInflammatory BiomarkersAcute Coronary Syndrome BiomarkersAtherosclerosis RiskAtherosclerotic ProgressionClinical Outcomes After Percutaneous Coronary InterventionCoronary StentingInflammation In Cardiovascular DiseaseInflammatory Cardiac BiomarkersLong-term Cardiovascular Follow-up
Background Soluble P-selectin (sP-selectin), a biomarker of inflammatory pathologies including cardiovascular disease, is known to have pro-atherosclerotic effects such as the ability to increase leukocyte recruitment and modulate thrombotic response. We aimed to assess the impact of sP-selectin on long-term major adverse cardiovascular events (MACE) in patients after coronary stenting for coronary artery disease. Methods We analysed 733 patients of a single-centre registry undergoing percutaneous coronary intervention (PCI) between 2003 and 2006. Plasma samples were analysed for sP-selectin antigen concentration with an enzyme-linked immunoassay. The study population was categorized according to sP-selectin quartiles. Endpoint of the study was long-term MACE, a composite of all-cause death, myocardial infarction (MI) and stroke. Results Of the total patient cohort, 361 (49.2%) patients were admitted for stable coronary artery disease and 372 (50.8%) for acute coronary syndrome. Median age was 64 years and 70.7% were male. After a mean follow-up period of 9.7 years, MACE occurred in 344 (46.9%) patients. The primary endpoint components of all-cause death occurred in 211 (28.8%), MI in 88 (12.0%) and ischaemic stroke in 45 (6.1%) patients. After adjustment for confounders, patients in the 2nd, 3rd and 4th quartile were at higher risk for MACE compared with the 1st quartile (hazard ration [HR], 1.234 [0.899–1.695], p = 0.193; HR, 1.480 [1.085–2.019], p = 0.013; and HR, 1.571 [1.115–2.152], p = 0.004). sP-selectin as continuous variable model was significantly associated with MACE after adjustment (HR per 1 ng/mL increase of 1.009 [95% confidence interval, 1.002–1.017]; p = 0.016). Conclusion Elevated levels of sP-selectin were associated with increased risk for long-term MACE in patients undergoing PCI.
31
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey, Lesley A. Stevens, Christopher H. Schmid et al. · Annals of Internal Medicine · 2009 · 25.7K citations
Pharmacy, Nephrology, Physiology +12
Purposeful selection of variables in logistic regression
Zoran Bursac, C. Heath Gauss, David Williams et al. · Source Code for Biology and Medicine · 2008 · 3.9K citations · Full text
Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice
Tanya N. Mayadas, Robert C. Johnson, Helen Rayburn et al. · Cell · 1993 · 1K citations
Rodger P. McEver, Jay H. Beckstead, Kevin L. Moore et al. · Journal of Clinical Investigation · 1989 · 985 citations · Full text